Alex Zhavoronkov, PhD to Present at LSX Nordic Congress (IMAGE)

InSilico Medicine

Alex Zhavoronkov, PhD to Present at LSX Nordic Congress

Caption

Dr. Zhavoronkov, founder and CEO of Insilico Medicine, will present on “‘How Artificial Intelligence is Shaping the Future of Drug Discovery, Design, and Development.”

Credit

Insilico Medicine

Usage Restrictions

none

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.